Federal Register Notice: FDA’s Anti-Infective Drugs Advisory Committee will meet 12/5 from 8 a.m. to 4:30 p.m. at the Marriott Inn and Conference Center, University of Maryland University College, The Ballroom, 3501 University Blvd. East, Adelphi, MD. The committee will discuss a Cerexa Inc. NDA for ceftazidime-avibactam for injection to treat complicated intra-abdominal infections, complicated urinary tract infections, including acute pyelonephritis and limited use indication: aerobic gram-negative infections with limited treatment options. Contact Jennifer Shepherd, (301) 796-9001. To view this notice, click here.